Addex Therapeutics Ltd ADR (ADXN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,381 | 7,975 | 6,046 | 7,290 | 10,789 |
| Receivables | 209 | 284 | 249 | 437 | 308 |
| Other current assets | 215 | 293 | 222 | 194 | 168 |
| TOTAL | $6,500 | $9,669 | $7,473 | $8,204 | $12,111 |
| Non-Current Assets | |||||
| PPE Net | 31 | 37 | 40 | 43 | 50 |
| Other Non-Current Assets | 416 | 304 | 371 | 432 | 510 |
| TOTAL | $448 | $341 | $410 | $475 | $560 |
| Total Assets | $6,947 | $10,010 | $7,883 | $8,679 | $12,671 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,952 | 2,797 | 3,203 | 3,140 | 3,978 |
| TOTAL | $2,186 | $3,019 | $3,444 | $3,439 | $4,274 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 297 | 176 | 39 | 91 | 167 |
| TOTAL | $297 | $176 | $39 | $91 | $167 |
| Total Liabilities | $2,483 | $3,195 | $3,483 | $3,531 | $4,440 |
| Shareholders' Equity | |||||
| Common Shares | 1,613 | 1,518 | 1,247 | 1,209 | 676 |
| Retained earnings | -404,688 | -394,840 | -380,697 | -366,620 | -358,362 |
| Other shareholders' equity | 109,265 | 107,843 | 98,362 | 95,139 | 94,764 |
| TOTAL | $4,464 | $6,815 | $4,400 | $5,148 | $8,231 |
| Total Liabilities And Equity | $6,947 | $10,010 | $7,883 | $8,679 | $12,671 |